10 DNA Stocks Billionaires Are Loading Up On
Genomics is the study of a complete set of DNA within an organism.
Crispr Therapeutics Ag (CRSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 7,338,447 | $411,980,394 | -9% | 2.72% |
| 2. | Armistice Capital Steven Boyd | 500,000 | $28,070,000 | -40% | 0.4% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 457,008 | $25,656,428 | 0.05% | |
| 4. | 407,700 | $22,888,278 | +120% | 0% | |
| 5. | 340,000 | $19,087,600 | +31% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.95 | 27,461 | Large Shareholder | 5,380,940 | 2018-12-27 | Filing | |
| $24.89 | 12,737 | Large Shareholder | 5,353,479 | 2018-12-26 | Filing | |
| $24.97 | 53,655 | Large Shareholder | 5,340,742 | 2018-12-24 | Filing | |
| $23.18 | 11,742 | Large Shareholder | 5,287,087 | 2018-12-24 | Filing | |
| $22.91 | 2,603 | Large Shareholder | 5,275,345 | 2018-12-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.83 | 2,400 | Officer, Director | 387,377 | 2023-05-30 | Filing | |
| $65.63 | 9,300 | Officer, Director | 389,777 | 2023-05-30 | Filing | |
| $64.46 | 5,999 | Officer, Director | 399,077 | 2023-05-30 | Filing | |
| $63.61 | 7,301 | Officer, Director | 405,076 | 2023-05-30 | Filing | |
| $51.45 | 4,393 | Officer, Director | 387,377 | 2023-04-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,069,723 | $340,754,249 | 0.08% | |
| 2. | 3,533,357 | $198,362,662 | 0.15% | |
| 3. | 3,533,357 | $198,327,328 | 2.08% | |
| 4. | 2,718,575 | $152,620,801 | 0% | |
| 5. | 2,091,173 | $117,398,452 | 0% |
News See All
12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential.
Top 5 CRISPR Stocks To Buy
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming.
12 Most Promising Healthcare Stocks According to Analysts
In this article, we will take a look at the 12 most promising healthcare stocks according to analysts.
5 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.
12 Cheap Healthcare Stocks to Buy in 2023
The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades.
10 Most Promising Biotech Stocks According to Analysts
Last year was a period of transition for biotech firms.
Ark Invest Stock Portfolio: 15 Biggest Positions
In this article, we discuss the 15 biggest positions in the ARK Invest portfolio.
5 Cheap Biotech Stocks To Buy
Since the company's July 2021 IPO, CRISPR Therapeutics AG (NASDAQ:CRSP) shares have fallen by 44%.
15 Most Advanced Countries in Europe
Over the course of recent human history, Europe has proven to be the bedrock of innovation.
Billionaire Hedge Funds
